BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22703928)

  • 21. Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trial.
    Petersen M; Andersen JT; Jimenez-Solem E; Broedbaek K; Afzal S; Nyegaard M; Børglum AD; Stender S; Torp-Pedersen C; Køber L; Poulsen HE
    Pharmacogenet Genomics; 2012 Oct; 22(10):709-15. PubMed ID: 22760495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers.
    Guerra LA; Lteif C; Arwood MJ; McDonough CW; Dumeny L; Desai AA; Cavallari LH; Duarte JD
    Pharmacogenomics J; 2022 Feb; 22(1):62-68. PubMed ID: 34642472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenergic receptor genotypes influence postoperative outcomes in infants in the Single-Ventricle Reconstruction Trial.
    Ramroop R; Manase G; Lu D; Manase D; Chen S; Kim R; Lee T; Mahle WT; McHugh K; Mitchell M; Tristani-Firouzi M; Wechsler SB; Wilder NS; Zak V; Lafreniere-Roula M; Newburger JW; Gaynor JW; Russell MW; Mital S
    J Thorac Cardiovasc Surg; 2017 Nov; 154(5):1703-1710.e3. PubMed ID: 28734628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Race and Beta-Blocker Survival Benefit in Patients With Heart Failure: An Investigation of Self-Reported Race and Proportion of African Genetic Ancestry.
    Luzum JA; Peterson E; Li J; She R; Gui H; Liu B; Spertus JA; Pinto YM; Williams LK; Sabbah HN; Lanfear DE
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29739794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of ADRB1, ADRB2, and COMT Genetic Polymorphisms on Postoperative Outcomes of Patients Undergoing Cardiac Valve Surgery.
    Dai S; Ma W; Qin G; Wang L; Wang E
    Clin Ther; 2021 Feb; 43(2):349-359.e2. PubMed ID: 33451866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
    Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial differences in the medical treatment of elderly Medicare patients with acute myocardial infarction.
    Allison JJ; Kiefe CI; Centor RM; Box JB; Farmer RM
    J Gen Intern Med; 1996 Dec; 11(12):736-43. PubMed ID: 9016420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the ADRB2 (rs2053044) polymorphism and angiotensin-converting enzyme-inhibitor blood pressure response in the African American Study of Kidney Disease and Hypertension.
    Anthony EG; Richard E; Lipkowitz MS; Bhatnagar V
    Pharmacogenet Genomics; 2015 Sep; 25(9):444-9. PubMed ID: 26111150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of beta-1 and beta-2 adrenergic receptor gene polymorphisms with myocardial infarction.
    Yilmaz A; Kaya MG; Merdanoglu U; Ergun MA; Cengel A; Menevse S
    J Clin Lab Anal; 2009; 23(4):237-43. PubMed ID: 19623647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survival.
    Kardia SL; Kelly RJ; Keddache MA; Aronow BJ; Grabowski GA; Hahn HS; Case KL; Wagoner LE; Dorn GW; Liggett SB
    BMC Med Genet; 2008 Oct; 9():93. PubMed ID: 18947427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetics and healthcare outcomes in patients with chronic heart failure.
    Kim KM; Murray MD; Tu W; Robarge J; Ding Y; Brater DC; Flockhart DA
    Eur J Clin Pharmacol; 2012 Nov; 68(11):1483-91. PubMed ID: 22543981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenergic receptor polymorphisms and platelet reactivity after treatment with dual antiplatelet therapy with aspirin and clopidogrel in acute coronary syndrome.
    Cuisset T; Hamilos M; Delrue M; Frère C; Verhamme K; Bartunek J; Saut N; Bonnet JL; Eijgelsheim M; Wijns W; Alessi MC; Barbato E
    Thromb Haemost; 2010 Apr; 103(4):774-9. PubMed ID: 20135061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
    Pacanowski MA; Zineh I; Li H; Johnson BD; Cooper-DeHoff RM; Bittner V; McNamara DM; Sharaf BL; Merz CN; Pepine CJ; Johnson JA
    J Transl Med; 2008 Mar; 6():11. PubMed ID: 18331634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of β-adrenergic receptor genes polymorphisms with incidence of subsequent cardiovascular events in Han Chinese patients with coronary artery disease.
    Li ZG; Wu H; Zhou YL; Chen ZJ; Meng JX; Yang JQ; Chen JY; Zhong SL
    Chin Med J (Engl); 2013; 126(24):4679-84. PubMed ID: 24342311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β
    Li Y; Yuan H; Sun L; Zhou Q; Yang F; Yang Z; Liu D
    Genet Test Mol Biomarkers; 2019 Feb; 23(2):124-137. PubMed ID: 30668166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methacholine PC20 in African Americans and whites with asthma with homozygous genotypes at ADRB2 codon 16.
    Blake K; Cury JD; Hossain J; Tantisira K; Wang J; Mougey E; Lima J
    Pulm Pharmacol Ther; 2013 Jun; 26(3):342-7. PubMed ID: 23384627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta2-adrenergic receptor genotype predicts survival: implications and future directions.
    Lanfear DE; Spertus JA; McLeod HL
    J Cardiovasc Nurs; 2006; 21(6):474-7. PubMed ID: 17293738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of 95 variants identified in a genome-wide study for association with mortality after acute coronary syndrome.
    Morgan TM; House JA; Cresci S; Jones P; Allayee H; Hazen SL; Patel Y; Patel RS; Eapen DJ; Waddy SP; Quyyumi AA; Kleber ME; März W; Winkelmann BR; Boehm BO; Krumholz HM; Spertus JA
    BMC Med Genet; 2011 Sep; 12():127. PubMed ID: 21957892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of β-blocker exposure with outcomes in heart failure differs between African American and white patients.
    Lanfear DE; Hrobowski TN; Peterson EL; Wells KE; Swadia TV; Spertus JA; Williams LK
    Circ Heart Fail; 2012 Mar; 5(2):202-8. PubMed ID: 22260944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of race on cardiac care and outcomes in veterans with acute myocardial infarction.
    Petersen LA; Wright SM; Peterson ED; Daley J
    Med Care; 2002 Jan; 40(1 Suppl):I86-96. PubMed ID: 11789635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.